European Journal of Surgical Oncology
Volume 33, Issue 1 , Pages 23-27 , February 2007

99MTechnetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography

  • G.M.M. Gommans

      Affiliations

    • Department of Nuclear Medicine, Westfries Hospital Hoorn, PO BOX 600, 1620 AR Hoorn, The Netherlands
    • Department of Nuclear Medicine (0030), Medical Centre Alkmaar, Wilhelminalaan 12, 1815 JD Alkmaar, The Netherlands
    • Corresponding Author InformationCorresponding author. Department of Nuclear Medicine (0030), Medical Centre Alkmaar, Wilhelminalaan 12, 1815 JD Alkmaar, The Netherlands. Tel.: +31 72 548 3480; fax: +31 72 548 3484.
    • ,
  • F.M. van der Zant

      Affiliations

    • Department of Nuclear Medicine (0030), Medical Centre Alkmaar, Wilhelminalaan 12, 1815 JD Alkmaar, The Netherlands
    • ,
  • A. van Dongen

      Affiliations

    • Department of Nuclear Medicine, Westfries Hospital Hoorn, PO BOX 600, 1620 AR Hoorn, The Netherlands
    • ,
  • R.O. Boer

      Affiliations

    • Department of Nuclear Medicine, Westfries Hospital Hoorn, PO BOX 600, 1620 AR Hoorn, The Netherlands
    • Department of Nuclear Medicine (0030), Medical Centre Alkmaar, Wilhelminalaan 12, 1815 JD Alkmaar, The Netherlands
    • ,
  • G.J.J. Teule

      Affiliations

    • Department of Nuclear Medicine, University Maastricht, P Debyelaan 25, 6229 HX, The Netherlands
    • ,
  • J.W.D. de Waard

      Affiliations

    • Department of Surgery, Westfries Hospital Hoorn, PO BOX 600, 1620 AR Hoorn, The Netherlands

,Accepted 16 October 2006.

References 

  1. Skaane P, Young K, Skennald A. Population-based mammography screening: comparison of screen-film and full-field digital mammography with soft-copy reading—Oslo I study. Radiology. 2003;229:877–884
  2. Skaane P. Ultrasonography as adjunct to mammography in the evaluation of breast tumors. Acta Radiol Suppl. 1999;420:1–47
  3. Khalkhali I, Villanueva-Meyer J, Sl Edell, et al. Diagnostic accuracy of 99mTc-Sestamibi breast imaging: multi centre results. J Nucl Med. 2000;41:1973–1079
  4. Danielson R, Bone B, Gad A, Sylvan M, Aspelin P. Sensitivity and specificity of planar scintimammography in the evaluation of breast lesions with 99mTc-sestamibi. Acta Radiol. 1999;40:394–399
  5. Taillefer R, Robidoux A, Lambert R, Turpin S, Laperriere J. Technetium-99m-sestamibi to detect primary breast cancer and axillary lymph node involvement. J Nucl Med. 1995;36:1758–1765
  6. Mekhmandarov S, Sandbank J, Cohen M, Lelcuk S, Lubin E. Technetium-99m-MIBI scintimammography in palpable and non-palpable lesions. J Nucl Med. 1998;86:91
  7. Danielson R, Reihner E, Grabowska A, Bone B. The role of scintimammography with 99m-Tc-sestamibi as a complementary diagnostic technique in the detection of breast cancer. Acta Radiol. 2000;41:441–445
  8. Palmedo H, Biersack HJ, Lastoria S, et al. Scintimammography with technetium-99m-metoxyisobutylisonitrile: results of a prospective European multicentre trial. Eur J Nucl Med. 1998;25:375–385
  9. Lumachi F, Ferritti G, Povolato M, et al. Accuracy of technetium-99m sestamibi scintimammography and X-ray mammography in premenopausal women with suspected cancer. Eur J Nucl Med. 2001;28:1776–1780
  10. Lumachi F, Zucchetta P, Marzola MC, et al. Positive predictive value of 99mTc sestamibi scintimammography in patients with non-palpable, mammographically detected, suspicious, breast lesions. Nucl Med Commun. 2002;23:1073–2078
  11. Buscombe JR, Cwikla JB, Holloway B, Hilson AJW. Prediction of the usefulness of combined mammography and scintimammography in suspected primary breast cancer using ROC curves. J Nucl Med. 2001;42:3–8
  12. Wilczek B, Aspelin P, Bone B, Pergerfalk A, Frisell J Danielsson R. Complementary use of scintimammography with 99m-Tc-MIBI to triple diagnosis procedure in palpable and non-palpable breast lesions. Acta Radiol. 2003;44:288–293
  13. Brem RF, Schoonjans JM, Kieper DA, Majewski S, Goodman S, Civelek C. High resolution scintimammography: a pilot study. J Nucl Med. 2002;43:909–915
  14. Leidenius MHK, Leppänen EA, Tykkä , van Smitten KAJ. The role of Tc99m-sestamibi scintimammography in combination with the tripple assessment op primary breast cancer. EJSO. 2002;28:108–112
  15. Bombardieri E, Aktolun C, Baum RP, et al. Breast scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2003;30:BP107-BP114
  16. Bone B, Wiberg MK, Szabo BK, Szakos A, Danielsson R. Comparison of 99mTc-sestamibi scintimammography and dynamic MR imaging as adjuncts to mammography in the diagnosis of breast cancer. Acta Radiol. 2003;44:28–34
  17. Tiling R, Sommer H, Pechmann M, et al. Comparison of technetium-99m sestamibi scintimammography with contrast-enhanced MRI for diagnosis of breast lesions. J Nucl Med. 1997;38:58–62
  18. Fondrinier E, Muratet JP, Anglade E, et al. Clinical experience with 99mTc-MIBI scintimammography in patients with breast microcalcifications. Breast. 2004;13(4):316–320
  19. Papantoniou V, Tsiouris S, Mainta E, et al. Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography. Breast Cancer Res. 2005;7(1):R33–R45
  20. Wang HC, Sun SS, Kao A, Lin CC, Lee CC. Comparison of technetium-99m methoxyisobutylisonitrile scintimammography and ultrasonography in the diagnosis of breast cancer in patients with mammagraphically dense breast. Cancer Invest. 2002;20:318–323
  21. Mathieu I, Mazy S, Willemart B, Destine M, Mazy G, Lonneux M. Inconclusive triple diagnosis in breast cancer imaging: is there a place for scintimammography?. J Nucl Med. 2005;46(10):1574–1581
  22. Myslivecek M, Koranda P, Kaminek M, et al. Technetium-99m-Mibi scintimammography by planar and SPECT imaging in the diagnosis of breast carcinoma and axillary lymph node involvement. Nucl Med Rev Cent East Eur. 2004;7(2):151–155
  23. Mulero F, Nicolas F, Castellon MI, Claver MA, Abad L. Nuno de la Rosa JA. Scintigraphy with 99mTc-MIBI in the diagnosis of axillary lymph node invasion of breast cancer. Rev Esp Med Nucl. 2000;19:416–422
  24. Sapino A, Cassoni P, Zanon E, et al. Ultrasonographically-guided fine-needle aspiration of axillary lymph nodes: role in breast cancer management. Br J Cancer. 2003;88:702–706
  25. Pedrosian I, Bedi D, Kuerer HM, et al. Impact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patients with breast cancer. Ann Surg Oncol. 2003;10:1025–1030
  26. Koukouraki S, Koukourakis MI, Vagios E, Velidaki A, Tsiftsis D, Karkavitsas N. The role of 99m Tc-sestamibi scintimammography and colour Doppler ultrasonography in the evaluation of breast lesions. Nucl Med Commun. 2001;22:1243–1248
  27. Bagni B, Francesschetto A, Casolo A, et al. Scintimammography with 99mTc-MIBI and magnetic resonance imaging in the evaluation of breast cancer. Eur J Nucl Med Mol Imaging. 2003;30:1383–1388
  28. Tiling R, Linke R, Untch M, et al. 18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative study. Eur J Nucl Med. 2001;28:711–720
  29. Danielson R, Bone B, Perbeck L, Aspelin P. Evaluation of planar scintimammography with 99m Tc-MIBI in the detection of axillary lymph node metastasis of breast carcinoma. Acta Radiol. 1999;40:491–495

PII: S0748-7983(06)00411-2

doi: 10.1016/j.ejso.2006.10.025

European Journal of Surgical Oncology
Volume 33, Issue 1 , Pages 23-27 , February 2007

Article Tools